NASA moves SunRISE off Vulcan Centaur to SpaceX Falcon Heavy after SRB nozzle anomaly
The switch hedges against a Vulcan Centaur freeze and forces SunRISE timing into a new, risk-managed launch path.
NASA will launch its SunRISE solar mission on a SpaceX Falcon Heavy instead of the United Launch Alliance Vulcan Centaur it originally booked. The change comes after a February Vulcan Centaur flight saw a booster anomaly that included burn-through of a solid rocket booster nozzle during a US Space Force launch.
NASA has performed a rocket switcheroo for its SunRISE solar observatory. Instead of flying on the United Launch Alliance Vulcan Centaur it was originally booked to use, SunRISE will now launch on a SpaceX Falcon Heavy, using a rideshare sponsored by the United States Space Force's Space Systems Command.
The timing pressure here is real, because the Vulcan Centaur problem is not theoretical. In February, the fourth Vulcan Centaur flight experienced a booster anomaly during a US Space Force launch. The payload made it to orbit, but burn-through of a Solid Rocket Booster (SRB) nozzle made the trip more eventful than planned. Space Force reportedly paused all national security launches on the Vulcan Centaur until the investigation was complete and appropriate corrective action was taken. SunRISE, originally due to launch on Vulcan in summer 2026 after completing its final prelaunch testing at the beginning of 2026, got caught in the fallout.
For decision-makers, the core issue is schedule risk under national security launch constraints. Vulcan Centaur had a role to play for the Space Force, and once a booster anomaly hits, the customer tends to get conservative fast.
This story's Key Insights and Take-aways are locked.
Create a free account to unlock Executive Actions for one credit.
Register to UnlockAlways free for Executives Club members. Join the Club
More in Science
2026 Nikon Small World Winners Reveal the Hidden Machinery of Everyday Life
A mycologist's frozen Edinburgh garden became the backdrop for vivid views inside cells, a reminder of what advanced imaging now makes visible to researchers and the industries built on biology.
Study: 1 in 4 depression cases may be a body-clock problem, not a chemical one
A 10,000-person study finds standard antidepressants often fail these patients, but melatonin and morning sunlight may hit the real root cause.
Start-Up Says A.I. Designed a Virus to Attack One Patient's Superbug
If the claim holds up, personalized phage therapy could become a new frontline weapon against antibiotic resistance - but proof is far from final.